Health care stocks rose Monday afternoon, with the NYSE Health Care Index adding 2% and the Health Care Select Sector SPDR Fund (XLV) up 2.1%.
The iShares Biotechnology ETF (IBB) rose 0.7%.
In corporate news, Walgreens Boots Alliance (WBA) shares fell 6.4% after CNBC's David Faber reported the company's talks with Sycamore Partners on a go-private deal are "mostly dead," according to media reports.
Sage Therapeutics (SAGE) said Monday its board rejected Biogen's (BIIB) unsolicited, non-binding proposal to buy Sage shares not already owned by Biogen for $7.22 per share. Sage shares rose 4.8% and Biogen was adding 1.8%.
Allakos (ALLK) said Monday its phase 1 trial of AK006 in chronic spontaneous urticaria failed to demonstrate therapeutic efficacy and that its development will be terminated immediately. Its shares dropped 78%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.